Vanda Pharmaceuticals (VNDA) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.19
-0.11
-0.03
0.05

Details

Expected EPS
-0.156667
Actual EPS
-0.09
Surprise EPS
0.07
Surprise Percent
+42.55%

Description

⁨Vanda Pharmaceuticals⁩ (⁦VNDA⁩) has reported earnings of ⁦-0.09⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts